A new study unveils a method to non-invasively monitor cell spatiotemporal dynamics involved in cancer progression in a ...

Through this, they identified five different cancer cell groups within a tumor, with distinct gene expression profiles that indicated vast differences in cell behavior.

Exelixis' STELLAR-303 trial shows zanzalintinib plus Tecentriq improved survival in colorectal cancer, with no new safety concerns reported.

A research group has developed a technology for mass-producing uniform artificial cells (lipid bilayer vesicles) with artificial model nuclei using microfluidic devices with high reproducibility ...

Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins—molecules that transport fat in blood—which enriches cancer cells with an antioxidant shield to ...

This can disrupt the cancer cell’s life cycle and may lead to cell death. The FDA granted accelerated approval to Zepzelca in June 2020 for those whose metastatic small cell lung cancer has progressed ...

Rising early-onset colorectal cancer rates among young adults highlight the urgent need to explore lifestyle, genetics, and environmental factors driving this trend.

By reprogramming myeloid cells using mRNA, researchers can equip them to detect and kill cancer cells with unprecedented precision.

Liquid biopsy tests are growing in use and showing promise in cancer detection, but experts say more trials are needed on the clinical benefit of ctDNA testing.

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline ...

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO ...

ASCO: Bicara ties antibody to 46% 2-year survival rate for head and neck cancer subset ...